GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (TSXV:AQS) » Definitions » Total Noninterest Expense

Aequus Pharmaceuticals (TSXV:AQS) Total Noninterest Expense


View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Total Noninterest Expense?

Total Noninterest Expense only applies to banks.


Aequus Pharmaceuticals Business Description

Traded in Other Exchanges
Address
200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Executives
Doug Janzen Director, Senior Officer